Dolly A. Vance

2015

In 2015, Dolly A. Vance earned a total compensation of $1.2M as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary at Rigel Pharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$202,108
Option Awards$476,735
Salary$475,548
Other$2,344
Total$1,156,735

Vance received $476.7K in option awards, accounting for 41% of the total pay in 2015.

Vance also received $202.1K in non-equity incentive plan, $475.5K in salary and $2.3K in other compensation.

Rankings

In 2015, Dolly A. Vance's compensation ranked 7,238th out of 13,638 executives tracked by ExecPay. In other words, Vance earned more than 46.9% of executives.

ClassificationRankingPercentile
All
7,238
out of 13,638
47th
Division
Manufacturing
2,724
out of 5,190
48th
Major group
Chemicals And Allied Products
977
out of 1,854
47th
Industry group
Drugs
785
out of 1,528
49th
Industry
Pharmaceutical Preparations
613
out of 1,182
48th
Source: SEC filing on March 29, 2017.

Vance's colleagues

We found four more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2015.

2015

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2015

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, of Discovery and Research

2015

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2015

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

News

You may also like